As of 2026-09-28, the Relative Valuation of Guardant Health Inc (GH) is (96.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 177.25 USD, the upside of Guardant Health Inc based on Relative Valuation is -154.2%.
The range of the Relative Valuation is (94.79) - (91.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.7x - 36.2x | 32.2x |
| Forward P/E multiples | 21.9x - 26.9x | 24.0x |
| Fair Price | (94.79) - (91.85) | (96.09) |
| Upside | -153.5% - -151.8% | -154.2% |
| Date | P/E |
| 2026-09-25 | -51.83 |
| 2026-09-24 | -51.60 |
| 2026-09-23 | -51.56 |
| 2026-09-22 | -51.81 |
| 2026-09-21 | -50.85 |
| 2026-09-18 | -52.46 |
| 2026-09-17 | -53.54 |
| 2026-09-16 | -51.15 |
| 2026-09-15 | -51.37 |
| 2026-09-14 | -49.08 |
| 2026-09-11 | -46.02 |
| 2026-09-10 | -46.51 |
| 2026-09-09 | -47.60 |
| 2026-09-08 | -47.08 |
| 2026-09-04 | -47.20 |
| 2026-09-03 | -47.09 |
| 2026-09-02 | -47.68 |
| 2026-09-01 | -48.08 |
| 2026-08-31 | -46.50 |
| 2026-08-28 | -47.23 |
| 2026-08-27 | -49.28 |
| 2026-08-26 | -49.98 |
| 2026-08-25 | -48.23 |
| 2026-08-24 | -47.72 |
| 2026-08-21 | -49.92 |
| 2026-08-20 | -49.09 |
| 2026-08-19 | -47.77 |
| 2026-08-18 | -46.82 |
| 2026-08-17 | -47.28 |
| 2026-08-14 | -45.97 |
| 2026-08-13 | -46.65 |
| 2026-08-12 | -48.28 |
| 2026-08-11 | -48.28 |
| 2026-08-10 | -48.90 |
| 2026-08-07 | -49.27 |
| 2026-08-06 | -46.08 |
| 2026-08-05 | -47.72 |
| 2026-08-04 | -46.73 |
| 2026-08-03 | -46.45 |
| 2026-07-31 | -47.37 |
| 2026-07-30 | -44.55 |
| 2026-07-29 | -42.13 |
| 2026-07-28 | -42.00 |
| 2026-07-27 | -42.54 |
| 2026-07-24 | -43.08 |
| 2026-07-23 | -43.92 |
| 2026-07-22 | -44.08 |
| 2026-07-21 | -44.53 |
| 2026-07-20 | -43.30 |
| 2026-07-17 | -45.58 |